Virtu Financial LLC Reata Pharmaceuticals Inc Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$20.71 - $36.5 $431,078 - $759,747	-20,815 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$24.12 - $39.6 $502,057 - $824,274	20,815 New	20,815 $682,000
Q3 2021 Nov 12, 2021	SELL	$100.0 - $143.02 $245,900 - $351,686	-2,459 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$78.27 - $151.29 $192,465 - $372,022	2,459 New	2,459 $348,000
Q2 2020 Aug 07, 2020	SELL	$126.3 - $176.56 $711,574 - $994,739	-5,634 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$74.57 - $217.92 $108,201 - $316,201	-1,451 Reduced 20.48%	5,634 $1.15 Million
Q3 2019 Nov 20, 2019	BUY	$71.26 - $95.75 $504,877 - $678,388	7,085 New	7,085 $569,000
Q2 2019 Aug 13, 2019	SELL	$77.72 - $94.35 $512,252 - $621,860	-6,591 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$51.9 - $101.79 $342,072 - $670,897	6,591 New	6,591 $563,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.